CG Oncology, Inc. (CGON) Tops Q3 EPS by 12c

CG Oncology, Inc. (NASDAQ: CGON) reported Q3 EPS of ($0.30), $0.12 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• JPMorgan Downgrades Kuaishou Technology (1024:HK) to Neutral
• RBC Capital Assumes Pepper Money Ltd (PPM:AU) at Sector Perform